Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Fluoroquinolone use and serious arrhythmias: A nationwide case-crossover study.

Porta L, Lee MG, Hsu WT, Hsu TC, Tsai TY, Lee CC.

Resuscitation. 2019 Jun;139:262-268. doi: 10.1016/j.resuscitation.2019.04.030. Epub 2019 Apr 25.

PMID:
31029713
2.

Oral Fluoroquinolone and the Risk of Aortic Dissection.

Lee CC, Lee MG, Hsieh R, Porta L, Lee WC, Lee SH, Chang SS.

J Am Coll Cardiol. 2018 Sep 18;72(12):1369-1378. doi: 10.1016/j.jacc.2018.06.067.

3.

Oral fluoroquinolone use and serious arrhythmia: bi-national cohort study.

Inghammar M, Svanström H, Melbye M, Pasternak B, Hviid A.

BMJ. 2016 Feb 26;352:i843. doi: 10.1136/bmj.i843.

5.

Fluoroquinolones and the risk of serious arrhythmia: a population-based study.

Lapi F, Wilchesky M, Kezouh A, Benisty JI, Ernst P, Suissa S.

Clin Infect Dis. 2012 Dec;55(11):1457-65. doi: 10.1093/cid/cis664. Epub 2012 Aug 3.

PMID:
22865870
6.

Association Between Oral Fluoroquinolone Use and Retinal Detachment.

Raguideau F, Lemaitre M, Dray-Spira R, Zureik M.

JAMA Ophthalmol. 2016 Apr;134(4):415-21. doi: 10.1001/jamaophthalmol.2015.6205.

PMID:
26967005
7.

Domperidone, cytochrome P450 3A4 isoenzyme inhibitors and ventricular arrhythmia: a nationwide case-crossover study.

Chen HL, Hsiao FY.

Pharmacoepidemiol Drug Saf. 2015 Aug;24(8):841-8. doi: 10.1002/pds.3814. Epub 2015 Jun 22.

PMID:
26098410
8.

Fluoroquinolones increase the risk of serious arrhythmias: A systematic review and meta-analysis.

Liu X, Ma J, Huang L, Zhu W, Yuan P, Wan R, Hong K.

Medicine (Baltimore). 2017 Nov;96(44):e8273. doi: 10.1097/MD.0000000000008273. Review.

9.
10.

Risks of cardiac arrhythmia and mortality among patients using new-generation macrolides, fluoroquinolones, and β-lactam/β-lactamase inhibitors: a Taiwanese nationwide study.

Chou HW, Wang JL, Chang CH, Lai CL, Lai MS, Chan KA.

Clin Infect Dis. 2015 Feb 15;60(4):566-77. doi: 10.1093/cid/ciu914. Epub 2014 Nov 18.

PMID:
25409476
11.

Risk of retinal tear or detachment with oral fluoroquinolone use: a cohort study.

Eftekhari K, Ghodasra DH, Haynes K, Chen J, Kempen JH, VanderBeek BL.

Pharmacoepidemiol Drug Saf. 2014 Jul;23(7):745-52. doi: 10.1002/pds.3623. Epub 2014 Apr 22.

12.

Macrolide and fluoroquinolone mediated cardiac arrhythmias: clinical considerations and comprehensive review.

Cornett E, Novitch MB, Kaye AD, Pann CA, Bangalore HS, Allred G, Bral M, Jhita PK, Kaye AM.

Postgrad Med. 2017 Sep;129(7):715-724. doi: 10.1080/00325481.2017.1362938. Epub 2017 Aug 10. Review.

PMID:
28770640
13.

Risk of Aortic Dissection and Aortic Aneurysm in Patients Taking Oral Fluoroquinolone.

Lee CC, Lee MT, Chen YS, Lee SH, Chen YS, Chen SC, Chang SC.

JAMA Intern Med. 2015 Nov;175(11):1839-47. doi: 10.1001/jamainternmed.2015.5389.

PMID:
26436523
15.

Oral Fluoroquinolones and the Risk of Uveitis.

Sandhu HS, Brucker AJ, Ma L, VanderBeek BL.

JAMA Ophthalmol. 2016 Jan;134(1):38-43. doi: 10.1001/jamaophthalmol.2015.4092.

16.

Risk of gastrointestinal perforation in patients taking oral fluoroquinolone therapy: An analysis of nationally representative cohort.

Hsu SC, Chang SS, Lee MG, Lee SH, Tsai YW, Lin SC, Chen ST, Weng YC, Porta L, Wu JY, Lee CC.

PLoS One. 2017 Sep 5;12(9):e0183813. doi: 10.1371/journal.pone.0183813. eCollection 2017.

17.

Assessment on Implantable Defibrillators and the Evidence for Primary Prevention of Sudden Cardiac Death [Internet].

Uhlig K, Balk EM, Earley A, Persson R, Garlitski AC, Chen M, Lamont JL, Miligkos M, Avendano EE.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2013 Jun 26.

18.

Fluoroquinolone-associated myasthenia gravis exacerbation: evaluation of postmarketing reports from the US FDA adverse event reporting system and a literature review.

Jones SC, Sorbello A, Boucher RM.

Drug Saf. 2011 Oct 1;34(10):839-47. doi: 10.2165/11593110-000000000-00000. Review.

PMID:
21879778
19.

QRS prolongation is strongly associated with life-threatening ventricular arrhythmias in children with dilated cardiomyopathy.

Dao DT, Hollander SA, Rosenthal DN, Dubin AM.

J Heart Lung Transplant. 2013 Oct;32(10):1013-9. doi: 10.1016/j.healun.2013.06.007. Epub 2013 Aug 6.

PMID:
23932443
20.

Evaluation of Clostridium difficile-associated diarrhea with a drug formulary change in preferred fluoroquinolones.

Walbrown MA, Aspinall SL, Bayliss NK, Stone RA, Cunningham F, Squier CL, Good CB.

J Manag Care Pharm. 2008 Jan-Feb;14(1):34-40.

Supplemental Content

Support Center